We highly recommend the PreserVision AREDS 2 Eye Vitamin & Mineral Supplement to anyone looking for an eye health supplement. We found that the Focus Select AREDS2 Based Eye Vitamin-Mineral ...

The approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...

Bausch Health faces $21 billion in debt, with $10 billion due by 2027 and a $2.4 billion loan due next year. Private equity ...

Banks and private credit firms are competing to provide at least $5 billion of debt financing to help fund a potential buyout ...

Bausch + Lomb Co. (NYSE:BLCO – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twelve ...

RECOMMENDED FORMULA: This formula includes lutein, zeaxanthin, zinc, copper, vitamin C, and vitamin E to exactly match the nutrient formula recommended by the AMD experts at the National Eye ...

RECOMMENDED FORMULA: This formula includes lutein, zeaxanthin, zinc, copper, vitamin C, and vitamin E to exactly match the nutrient formula recommended by the AMD experts at the National Eye ...

Investing.com -- Bausch + Lomb (NYSE:BLCO) is exploring a potential ... This has caused its market value to fall to $2.2 billion, raising concerns about the company's financial stability.

Monday was an eventful day for Bausch + Lomb (NYSE: BLCO). The eye care specialist's major piece of internal news was that it earned its latest Food and Drug Administration (FDA) approval.

Bausch + Lomb (NYSE:BLCO – Free Report) had its price objective raised by Royal Bank of Canada from $20.00 to $23.00 in a report released on Tuesday morning, Benzinga reports. Royal Bank of Canada ...

1,2* VAUGHAN, Ontario, May 29, 2024--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see better to ...